Herpes Encephalitis: A Mortal Complication in a Patient Treated with Immunosuppressive Drugs because of Immune-Related Adverse Events after Ipilimumab Treatment

Until a few years ago, metastatic melanoma had a poor prognosis with limited treatment options. These therapeutics options and thereby median survival have increased obviously over 5 years with the arrival of immunotherapeutic drugs like ipilimumab, nivolumab, and pembrolizumab. Nowadays, ipilimumab...

Descripción completa

Detalles Bibliográficos
Autores principales: van Montfort, Lieke, Loos, Caroline M., Anten, Monique, Jansen, Rob L.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803703/
https://www.ncbi.nlm.nih.gov/pubmed/29430235
http://dx.doi.org/10.1159/000484553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803703/
https://www.ncbi.nlm.nih.gov/pubmed/29430235
http://dx.doi.org/10.1159/000484553

Ejemplares similares